Literature DB >> 7059613

Reversible depression of the reticuloendothelial system by liposomes.

H Ellens, E Mayhew, Y M Rustum.   

Abstract

The effect of various doses of different types (reverse phase evaporation vesicles and small unilamellar vesicles) of intravenously injected liposomes on reticuloendothelial activity, as measured by the blood clearance rate of intravenously injected carbon, was investigated. Also the effect of pretreatment with reverse phase evaporation vesicles on blood clearance and tissue distribution of a second dose of similar vesicles was determined. For all concentrations used reverse phase evaporation vesicles caused a reduction in reticuloendothelial activity at least up to 4 h after injection. 24 h after administration the rate of carbon clearance returned to the control level. On the contrary small unilamellar vesicles did not block reticuloendothelial activity. Pretreatment with reverse phase evaporation vesicles (250 mumol/kg) caused an increased blood level and a decreased hepatic uptake of a second dose of the vesicles, injected 1 h after the first dose. This seems to be due to a depression of reticuloendothelial activity and not to a depletion of opsonins. Pretreatment with small unilamellar vesicles (250 mumol/kg) had no significant influence on the tissue distribution of a second dose of vesicles. Our results clearly indicate that reverse phase evaporation vesicles cause a reversible depression of reticuloendothelial activity and this depression seems to be induced by a saturation of reticuloendothelial cells with liposomes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059613     DOI: 10.1016/0304-4165(82)90157-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

Review 1.  Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective.

Authors:  R M Fielding
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

2.  Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system.

Authors:  E W van Etten; M T ten Kate; S V Snijders; I A Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

Review 3.  Pharmacokinetic and Pharmacodynamic Properties of Drug Delivery Systems.

Authors:  Patrick M Glassman; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2019-03-05       Impact factor: 4.030

4.  Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome): a 91-day study in rats.

Authors:  I Bekersky; G W Boswell; R Hiles; R M Fielding; D Buell; T J Walsh
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

5.  Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey.

Authors:  R M Fielding; L Moon-McDermott; R O Lewis; M J Horner
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

6.  Suppression of liver uptake of liposomes by dextran sulfate 500.

Authors:  K R Patel; M P Li; J D Baldeschwieler
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Immune clearance of liposomes inhibited by an anti-Fc receptor antibody in vivo.

Authors:  D Aragnol; L D Leserman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

8.  Clearance and maximum removal rate of liposomes in normal and impaired liver of rat.

Authors:  M Ogiwara
Journal:  Gastroenterol Jpn       Date:  1984-02

9.  Improved Tumor Uptake by Optimizing Liposome Based RES Blockade Strategy.

Authors:  Xiaolian Sun; Xuefeng Yan; Orit Jacobson; Wenjing Sun; Zhantong Wang; Xiao Tong; Yuqiong Xia; Daishun Ling; Xiaoyuan Chen
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

10.  Macrophage depletion increases target specificity of bone-targeted nanoparticles.

Authors:  Marian A Ackun-Farmmer; Baixue Xiao; Maureen R Newman; Danielle S W Benoit
Journal:  J Biomed Mater Res A       Date:  2021-07-28       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.